Tate & Lyle PLC

TATE: XLON (GBR)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
S<&LOCK|qP@YrLOCK|n<hgYn

Tate & Lyle Earnings: Price Investments and Portfolio Repositioning Should Drive Volume Recovery

Tate & Lyle reported another 3% revenue decline on a pro forma basis for the fiscal year ending March 2026, while sales accelerated sequentially in the fourth quarter. Management acknowledged disappointing results due to soft demand but expects sales momentum to build in the future.

Sponsor Center